Neonatal NEC (necrotizing enterocolitis): a complete nursing reference

Necrotizing enterocolitis (NEC) is the most common and most devastating gastrointestinal emergency in the NICU. Large US and Canadian network databases put its prevalence at about 7% of infants with a birthweight of 500–1,500 g, though reported incidence varies widely between centers. The associated death rate is estimated at 20–30%, highest among infants who need surgery. In a Vermont Oxford Network cohort of 177,618 very low birthweight (VLBW) infants born 2006–2010, in-hospital mortality was 38% after laparotomy-confirmed NEC, double the 19% seen after spontaneous intestinal perforation, and mortality fell as birthweight rose. Survivors face a significant risk of short bowel syndrome, neurodevelopmental impairment, and prolonged NICU stays.

For nursing students, NEC sits at the intersection of prematurity physiology, infectious disease, gastrointestinal pathology, and surgical nursing. Understanding it well means understanding why breast milk is a clinical intervention, why an abdominal X-ray finding can trigger a surgical emergency, and why subtle signs like feeding intolerance and temperature instability deserve urgent attention in a preterm infant.

This reference covers the pathophysiology, Bell’s modified staging criteria, clinical recognition, diagnostic workup, medical management, surgical indications, post-surgical nursing care, and 10 high-yield NCLEX tips. Use it alongside the neonatal nursing reference for broader NICU context, the neonatal sepsis nursing guide for the sepsis differential and complication pathway, and the neonatal RDS reference for prematurity as a shared risk framework.

Pathophysiology: mucosal injury and bacterial invasion

NEC develops through a convergence of three factors: an immature intestinal barrier, an exaggerated inflammatory response, and microbial colonization. Prematurity is the primary driver – the great majority of NEC cases occur in premature infants, and incidence rises as gestational age and birthweight fall. Infants born before 28 weeks carry the highest absolute risk.

The intestinal mucosa in the preterm neonate has several structural and functional vulnerabilities that distinguish it from the term gut. Tight junction proteins are incompletely expressed, allowing luminal antigens and bacteria to breach the epithelial barrier. Secretory IgA – the principal mucosal immunoglobulin – is absent or insufficient until it can be acquired through breast milk. Toll-like receptor 4 (TLR4), a pattern recognition receptor on intestinal epithelial cells, is overexpressed in the preterm gut relative to TLR9. This imbalance means the premature intestine mounts a disproportionately strong pro-inflammatory response to gram-negative bacterial lipopolysaccharide (LPS), while simultaneously suppressing the anti-inflammatory signals that would normally limit the damage.

When luminal bacteria – most commonly gram-negative enteric organisms – breach the mucosal barrier, TLR4 activation triggers a cascade of cytokine release, neutrophil infiltration, and oxidative stress. The resulting inflammation causes transmural necrosis of the intestinal wall. As necrosis progresses, gas-producing bacteria colonize the damaged wall, producing the intramural gas that is the radiographic signature of NEC – pneumatosis intestinalis. If the process continues unchecked, gas tracks into the portal venous system (portal venous gas), the bowel perforates, and intestinal contents spill into the peritoneum, causing peritonitis and septic shock.

Breast milk vs formula: a critical risk difference

The feeding substrate has a measurable effect on NEC risk. In Lucas and Cole’s prospective multicenter study of 926 preterm infants, confirmed NEC was 6–10 times more common in exclusively formula-fed infants than in those fed breast milk alone, and 3 times more common than in infants who received formula plus breast milk. The protective mechanisms are multiple: breast milk provides secretory IgA, lactoferrin, lysozyme, oligosaccharides that promote Bifidobacterium colonization, epidermal growth factor that supports mucosal integrity, and cytokines that modulate the neonatal inflammatory response. Pasteurized donor breast milk is the recommended alternative when maternal milk is unavailable. Pasteurization reduces some of its bioactive components, but the 2024 Cochrane review (12 trials, 2,296 infants) found high-certainty evidence that donor milk roughly halves NEC risk compared with formula in very preterm or VLBW infants (RR 0.53, 95% CI 0.37–0.76).

Formula-fed VLBW infants are at higher risk partly because formula lacks these bioactive components, and partly because formula feeding is associated with a different gut microbiome composition – with higher proportions of Proteobacteria and lower proportions of Lactobacillus and Bifidobacterium species.

Other established risk factors include formula supplementation in the context of VLBW, polycythemia (which reduces mesenteric blood flow), congenital heart disease (which creates intestinal ischemia through low cardiac output or ductal steal), and, in some studies, early enteral feeding advancement. That last factor has weakened under randomized testing: the 2021 Cochrane review of slow versus faster advancement of feed volumes (14 trials, 4,026 VLBW or very preterm infants) found that slow advancement probably does not reduce NEC (RR 1.06, moderate-certainty evidence), so advancing feeds slowly should not be presented as an evidence-based NEC prevention measure. The role of red blood cell transfusions in precipitating transfusion-associated NEC (TANEC) remains an area of active investigation.

Probiotics: evidence and US regulatory status

Probiotics are the most debated NEC prevention strategy. The 2023 Cochrane review (60 trials, 11,156 infants) found probiotics may reduce NEC in very preterm or VLBW infants (RR 0.54, low-certainty evidence; number needed to treat 33), but showed little or no effect on NEC in extremely preterm or extremely low birthweight infants (RR 0.92), the group at highest risk. The AAP’s 2021 clinical report concluded that current evidence does not support routine, universal probiotic administration to preterm infants, particularly those under 1,000 g, citing the lack of FDA-regulated pharmaceutical-grade products. In September 2023 the FDA warned health care providers that preterm infants given probiotics are at risk of invasive, potentially fatal infection from the organisms in the product, after an infant under 1,000 g died of Bifidobacterium longum sepsis genetically matched to the probiotic given. If your unit uses probiotics, follow its protocol and consent process.

Bell’s modified staging criteria

The modified Bell’s staging system, developed by Bell in 1978 and refined by Walsh and Kliegman in 1986, stratifies NEC by systemic, intestinal, and radiographic severity. It remains the most widely used staging system in NICUs, although critics argue it fits today’s extremely preterm population less well and can blur NEC with spontaneous intestinal perforation. The criteria below follow the Walsh and Kliegman table as reproduced by Gregory and colleagues (2011). Each stage includes all signs of the stage before it.

Two staging details are commonly mixed up. Gross (bright red) rectal bleeding on its own is a Stage IB sign, so it does not by itself make NEC “definite”; pneumatosis on X-ray is what moves an infant into Stage II. Metabolic acidosis and thrombocytopenia first appear as criteria at Stage IIB.

Clinical signs: the NEC triad and subtle red flags

The classic triad of NEC is abdominal distension, blood in the stool, and pneumatosis intestinalis on X-ray. Operational case definitions, such as the one in the NHS Data Dictionary, follow the same logic: at least one clinical sign (bilious gastric aspirate, emesis, abdominal distension, or occult or gross blood in the stool) plus a radiological sign (pneumatosis, hepatobiliary gas, or pneumoperitoneum). The full picture often presents late or incompletely. In practice, NEC announces itself through signs that are individually non-specific and easy to attribute to other common NICU diagnoses.

Gastrointestinal signs:

• Abdominal distension (most consistent early sign – monitor girth measurement at every nursing assessment)
• Bilious (green) or bloody gastric residuals on feeding tube aspiration
• Grossly bloody stools (bright red or maroon)
• Absent or markedly diminished bowel sounds
• Abdominal wall discoloration or erythema (indicates transmural involvement or perforation – late, ominous sign)

Systemic signs:

• Temperature instability (hypothermia more common than fever in premature infants, mirroring neonatal sepsis physiology)
• Apnea and bradycardia (particularly new onset or worsening episodes in a previously stable infant)
• Lethargy, decreased tone
• Poor perfusion: pallor, mottling, prolonged capillary refill time (>3 seconds)
• Metabolic instability overlapping with neonatal hypoglycemia – glucose dysregulation is common as physiological stress mounts

Key nursing assessment point: In any preterm infant who develops new-onset feeding intolerance combined with any systemic sign – temperature instability, apnea, or poor perfusion – the threshold to notify the provider and consider NEC workup should be very low. Do not attribute bilious residuals to a pulled feeding tube or attribute abdominal distension to normal gas. Verify. Report. Document.

Radiographic findings

Plain abdominal X-rays (supine and left lateral decubitus views) are the primary imaging modality for NEC. Understanding the specific X-ray findings maps directly to Bell’s staging and guides the urgency of management decisions.

Pneumatosis intestinalis: The pathognomonic finding for NEC. Appears as bubbly or linear lucencies within the bowel wall – representing gas produced by bacteria within the intestinal wall. It can be subtle (a small cluster of bubbles in the right lower quadrant) or extensive (diffuse bubbly pattern across multiple bowel segments). Its presence confirms NEC Stage IIA or higher and requires immediate surgical consultation.

Portal venous gas: Gas tracking into the portal venous system, appearing as linear branching lucencies overlying the liver shadow on plain film. Indicates Stage IIB or III. Portal venous gas is an ominous sign – it means bacterial gas has dissected through the bowel wall and entered the mesenteric venous circulation. It does not automatically require surgery, but is associated with higher NEC severity and increased mortality.

Pneumoperitoneum: Free air in the peritoneal cavity – visible as a lucent crescent under the diaphragm on upright view, or over the liver on left lateral decubitus. Represents intestinal perforation and is a surgical emergency. In preterm infants too unstable for surgery, a bedside peritoneal drain may be placed as a temporizing measure.

Fixed dilated loops (persistent loop sign): A dilated bowel loop that stays in the same position, size, and configuration across serial X-rays raises concern for a non-viable segment. Wexler first described it in 1978, when the sign preceded perforation or proven bowel necrosis in all five infants reported. It is not a stand-alone surgical criterion: in a later series, 4 of 7 infants with the sign had necrotic bowel, but so did 4 of 14 infants without it. Treat it as a reason for surgical re-evaluation, weighed alongside the clinical picture, even if pneumoperitoneum is not yet present.

Abdominal ultrasound is increasingly used as a complementary tool – it can detect portal venous gas earlier than X-ray, assess bowel wall perfusion, detect ascites, and characterize the presence of free fluid. Bowel wall thinning or absent peristalsis on ultrasound carries independent prognostic weight.

Medical management

Medical management of NEC centers on five parallel priorities: bowel rest, decompression, nutritional support, infection control, and monitoring.

NPO and orogastric decompression

All infants with confirmed NEC (Stage IIA or higher) are made nil per os (NPO) for 7–14 days, depending on staging severity and clinical response. This removes the substrate for continued bacterial proliferation and eliminates the mechanical stress of enteral feeds on inflamed bowel. Orogastric (OG) or nasogastric (NG) tube decompression on continuous low suction removes gas and secretions from the stomach, reducing distension and the risk of aspiration.

The duration of NPO is one of the most NCLEX-tested aspects of NEC management. For definite medical NEC, Neu and Walker describe bowel rest for approximately 7–10 days; more advanced disease is often rested for up to about 14 days. Duration is guided by clinical and radiographic resolution and varies between units.

Total parenteral nutrition (TPN)

While the gut is rested, nutritional requirements are met entirely through TPN delivered via a PICC line or surgically placed central venous catheter. TPN for a VLBW neonate is a complex formulation requiring careful management of glucose infusion rate, amino acid provision for protein synthesis and brain development, lipid emulsion for essential fatty acid supplementation and caloric density, and electrolytes – particularly sodium, potassium, calcium, and phosphorus.

Nursing responsibilities include: monitoring the TPN infusion site for extravasation or signs of line infection, monitoring daily weights and fluid balance, tracking glucose via point-of-care testing (TPN increases hyperglycemia risk), and monitoring triglyceride levels if lipid emulsion is running.

Central line-associated bloodstream infection (CLABSI) prevention during prolonged TPN is critical. Bundle components: sterile technique during all line accesses, daily assessment of line necessity, and hand hygiene compliance. The infant already has a compromised intestinal barrier; a CLABSI on top of NEC significantly worsens prognosis.

Empiric antibiotic therapy

Antibiotic coverage targets the three major bacterial categories involved in NEC pathogenesis: gram-positive organisms (primarily Staphylococcus and Streptococcus species), gram-negative enteric bacilli (E. coli, Klebsiella, Pseudomonas), and anaerobes (Clostridium perfringens, Bacteroides fragilis). Standard empiric triple therapy covers all three:

Antibiotic duration for confirmed NEC is typically 7–14 days; blood culture results should guide narrowing. If blood cultures are negative at 48–72 hours and clinical condition is improving, some centers discontinue or de-escalate to a shorter course. Cultures of peritoneal fluid obtained at the time of surgery or drain placement also guide definitive therapy.

Monitoring priorities during medical management

Nursing assessment frequency increases during NEC treatment. At minimum:

• Abdominal girth measurement every 4–6 hours (mark the measuring site with a permanent marker for consistency)
• Serial abdominal X-rays every 6–8 hours (per physician/NNP orders) – be ready to position the infant correctly and minimize handling time
• Vital signs including blood pressure every 1–4 hours depending on severity
• Urine output (goal ≥ 1 mL/kg/h); oliguria suggests renal hypoperfusion or evolving AKI – see the AKI nursing reference
• Stool assessment for blood (guaiac testing if gross blood not apparent)
• Point-of-care glucose every 4–6 hours
• Complete blood count and metabolic panel every 12–24 hours; a sudden fall in the platelet or neutrophil count suggests the disease is progressing, and thrombocytopenia is one of the criteria that defines Stage IIB

NEC vs spontaneous intestinal perforation (SIP)

Spontaneous intestinal perforation is a distinct condition that is frequently confused with NEC, because both present with intestinal perforation in premature infants. Differentiating them matters clinically because SIP often does not require bowel resection and has a different prognosis.

From a nursing standpoint, the distinction matters when communicating with families – SIP is not NEC, carries a somewhat better prognosis, and does not imply the same pattern of ongoing bowel necrosis.

Surgical management

Surgery for NEC is indicated when medical management fails or when specific anatomical findings demand it. The indications are:

• Pneumoperitoneum – free air on abdominal X-ray indicating perforation (absolute surgical indication, Bell Stage IIIB)
• Clinical deterioration despite maximal medical management – persistent or worsening metabolic acidosis, escalating vasopressor requirements, rising lactate, worsening coagulopathy despite transfusion
• Peritonitis – diffuse abdominal tenderness, rigidity, erythema with systemic sepsis
• Persistent fixed loop on serial X-rays suggesting non-viable bowel (a relative indication, interpreted with the clinical picture)

Surgical options

Exploratory laparotomy with bowel resection is the standard approach for stable-enough infants. The surgeon removes all necrotic bowel – which may be patchy or extensive – and creates an ostomy (ileostomy or colostomy) to divert the fecal stream and protect the anastomosis from a gut already compromised by infection and inflammation. Primary anastomosis (reconnecting bowel ends immediately) is performed in select cases where the remaining bowel is healthy and the infant is stable, but ostomy creation is more common in the acute NEC setting.

Peritoneal drain placement is used as a primary or temporizing procedure for extremely premature or critically unstable infants (usually <1,000 g) who cannot tolerate a laparotomy. A small drain is placed through the abdominal wall at the bedside to decompress the peritoneum and remove contaminated fluid. In the NICHD Neonatal Research Network NEST trial (310 ELBW infants randomized to initial laparotomy or initial drainage), 50% of infants in the drain group went on to a later laparotomy. The trial found no overall difference in death or neurodevelopmental impairment at 18–22 months (69% vs 70%), but the preoperative diagnosis changed the picture: for presumed NEC, death or impairment occurred in 69% after laparotomy vs 85% after drainage (97% Bayesian probability that laparotomy is better), while for presumed isolated perforation the figures were 69% vs 63%.

Extent of resection and short bowel syndrome risk

The amount of bowel remaining determines long-term nutritional prognosis. Intestinal length roughly doubles in late gestation: in an autopsy series, total intestinal length rose from about 142 cm at 19–27 weeks to about 304 cm after 35 weeks, so the same residual length means more in a preterm infant, whose bowel will keep growing. Retaining the ileocecal valve and colon also improves the outlook. Short bowel syndrome and intestinal failure are defined functionally, by dependence on parenteral nutrition (PN) – in the Pediatric Intestinal Failure Consortium, PN for more than 60 consecutive days. NEC was the single most common cause in that cohort (26% of 272 infants), median residual small bowel length was 41 cm, and only 47% reached enteral autonomy, with 27% dying and 26% undergoing intestinal transplantation. Complications include PN-associated cholestatic liver disease, central line infections, and growth failure.

Post-surgical nursing care

Post-operative NEC nursing is complex, multi-system, and prolonged. The infant who has undergone bowel resection and ostomy creation requires:

Ostomy care:

• Assess stoma color at every diaper change – the stoma should be pink-red and moist; a pale, dark, or dusky stoma suggests ischemia and requires immediate provider notification
• Measure ostomy output – high-output ostomies cause electrolyte losses (particularly sodium and bicarbonate) and may need replacement fluids or supplementation; know your unit’s threshold for reporting output
• Use appropriately sized ostomy appliances; the preterm abdomen is tiny and skin surrounding the stoma is fragile – barrier paste and careful appliance selection prevent peristomal skin breakdown
• Document stool character (consistency, color, presence of blood)

TPN management:

• Continue TPN until the gut has healed and enteral feeds are advancing adequately to meet nutritional requirements
• Monitor for TPN-associated cholestasis: rising direct bilirubin, conjugated hyperbilirubinemia (a different mechanism from the unconjugated hyperbilirubinemia of neonatal jaundice – see neonatal jaundice nursing for comparison)
• Cycling TPN (alternating on/off over 24 hours) helps reduce cholestasis risk once enteral intake is partially established

Reintroduction of enteral feeds: Timing varies by unit and by the extent of surgery; feeds restart once bowel function returns (confirmed by ostomy output and clinical stability). The usual first step is trophic feeding – very small volumes (trials define trophic feeding as up to 24 mL/kg/day) using expressed maternal breast milk whenever possible. Its purpose is mucosal stimulation and gut rehabilitation; calories still come from parenteral nutrition at this stage. Feeds are then advanced slowly according to the unit’s feeding protocol, with close monitoring for re-emergence of feeding intolerance.

Breast milk is the preferred substrate for post-NEC trophic feeding because of its mucosal-protective properties. If maternal milk is unavailable, many units use pasteurized donor milk; elemental or semi-elemental formulas are another option, chosen for their reduced antigen load in a compromised gut.

Systemic monitoring:

• Continued close monitoring of platelet count, coagulation indices, and inflammatory markers as surgery-related inflammatory response resolves
• Watch for DIC – systemic inflammation from NEC plus surgical stress increases coagulopathy risk; the DIC nursing reference covers management
• Renal function: AKI is a recognized complication of NEC and perioperative stress; monitor BUN, creatinine, and urine output (see AKI nursing)
• Neurodevelopmental follow-up: NEC survivors have a higher incidence of neurodevelopmental impairment than gestational-age-matched peers – families need anticipatory guidance about developmental follow-up

Ostomy reversal: Ostomy takedown (reconnection of the bowel) is performed once the infant has grown and stabilized, provided the distal bowel is confirmed patent and healthy. Timing varies by center and by the infant’s growth and stoma output; a high-output proximal stoma is a common reason to reverse earlier. Prior to reversal, a distal loopogram (contrast study through the ostomy to image the distal bowel segment) is performed. Post-reversal nursing care focuses on return of normal stooling pattern and monitoring for anastomotic complications.

NCLEX tips for NEC

1. Pneumatosis intestinalis is pathognomonic for NEC. It is the single most important X-ray finding – if a question describes intramural gas or bubbly lucencies in the bowel wall, the answer is NEC until proven otherwise.

2. Breast milk is a clinical intervention. Confirmed NEC was 6–10 times more common in exclusively formula-fed preterm infants than in those fed breast milk alone (Lucas and Cole), and donor milk roughly halves NEC risk compared with formula (Cochrane 2024). NCLEX questions about NEC prevention will favor breastfeeding/breast milk provision as the correct intervention.

3. NPO duration: about 7–14 days. This is frequently tested. Roughly 7–10 days for definite (Stage II) medical NEC, and up to about 14 days for more advanced disease, guided by clinical and radiographic resolution. Knowing this range distinguishes NEC from other GI conditions with shorter bowel rest periods.

4. Bell Stage III = surgical emergency. Stage IIIB (pneumoperitoneum) is an absolute surgical indication. Stage IIIA (severe illness with intact bowel) leads to surgery if the infant keeps deteriorating despite maximal medical management.

5. Empiric triple antibiotic therapy = ampicillin + gentamicin + metronidazole. Remember the rationale: ampicillin covers gram-positive, gentamicin covers gram-negative, metronidazole covers anaerobes. If an NCLEX question asks which antibiotic covers anaerobes in the NEC regimen, the answer is metronidazole.

6. Classic NEC triad: abdominal distension + bloody stools + pneumatosis intestinalis. Temperature instability, apnea, and lethargy are common systemic signs, but they are nonspecific and overlap with sepsis. On NCLEX, abdominal distension and bloody stools in a premature neonate with feeding intolerance should lead directly to NEC as the priority concern, and pneumatosis on X-ray confirms it.

7. Monitor platelet count – thrombocytopenia marks Stage IIB. In modified Bell staging, mild metabolic acidosis and mild thrombocytopenia are Stage IIB criteria, and a sudden fall in platelet or neutrophil count signals progression. The correct nursing action is to notify the provider and prepare for blood product support.

8. Portal venous gas = ominous but not automatically surgical. Portal venous gas elevates the staging to IIB/III and warrants urgent surgical consultation, but unlike pneumoperitoneum, it is not automatically a surgical emergency. NCLEX questions may test this distinction – portal venous gas → urgent consult; pneumoperitoneum → surgery.

9. Post-surgical feeds should restart with expressed breast milk using trophic feeding. Trophic feeding means very small volumes (up to about 24 mL/kg/day in trial definitions) for gut mucosal rehabilitation; nutrition still comes mainly from PN. Breast milk is always preferred over formula in the post-NEC gut.

10. Short bowel syndrome is the major long-term complication. When the question asks about a complication following bowel resection for NEC, short bowel syndrome (chronic malabsorption, PN dependence, growth failure) is the high-yield answer. NEC is the most common single cause of pediatric intestinal failure, and the risk rises as residual bowel length falls, especially if the ileocecal valve and colon are lost.

Nursing priorities by stage

Key takeaways

NEC is a disease of prematurity, with the gut’s immaturity as both the initiating vulnerability and the therapeutic target. The critical clinical skills are recognizing the early and non-specific signs before the disease progresses to Stage III, understanding the cascade of radiographic findings and what each one means for management, and knowing when medical management is no longer sufficient and surgical escalation is required.

For nursing students: memorize Bell’s staging, the triple antibiotic regimen, the NPO duration, and the pathognomonic X-ray finding. Understand why breast milk matters mechanistically – this is a recurrent NCLEX theme. And know that abdominal distension and bloody stools in a premature infant, especially with new systemic instability, should always trigger the NEC differential first.

For further reading on the broader neonatal care context, see the neonatal nursing reference. For systemic inflammatory response and sepsis physiology, see both neonatal sepsis nursing and the systemic sepsis reference.

References

1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–264. doi:10.1056/NEJMra1005408
2. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7. doi:10.1097/00000658-197801000-00001
3. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33(1):179–201. doi:10.1016/S0031-3955(16)34975-6
4. Sharif S, Meader N, Oddie SJ, Rojas-Reyes MX, McGuire W. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2023;7(7):CD005496. doi:10.1002/14651858.CD005496.pub6
5. Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562–567.e1. doi:10.1016/j.jpeds.2009.10.040
6. Gephart SM, Hanson C, Wetzel CM, et al. NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitis. Matern Health Neonatol Perinatol. 2017;3:23. doi:10.1186/s40748-017-0062-0
7. Robinson JR, Rellinger EJ, Hatch LD, et al. Surgical necrotizing enterocolitis. Semin Perinatol. 2017;41(1):70–79. doi:10.1053/j.semperi.2016.09.020
8. Gordon PV, Swanson JR, Attridge JT, Clark R. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell’s criteria? J Perinatol. 2007;27(11):661–671. doi:10.1038/sj.jp.7211782
9. Swanson JR, Hair A, Clark RH, Gordon PV. Spontaneous intestinal perforation (SIP) will soon become the most common form of surgical bowel disease in the extremely low birth weight infant. J Perinatol. 2022;42(4):423–429. doi:10.1038/s41372-022-01347-z
10. Attridge JT, Clark R, Gordon PV. New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation. J Perinatol. 2006;26(11):667–670. doi:10.1038/sj.jp.7211589
11. Hu X, Liang H, Li F, et al. Necrotizing enterocolitis: current understanding of the prevention and management. Pediatr Surg Int. 2024;40(1):32. doi:10.1007/s00383-023-05619-3
12. Frost BL, Modi BP, Jaksic T, Caplan MS. New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr. 2017;171(1):83–88. doi:10.1001/jamapediatrics.2016.2708
13. Han SM, Hong CR, Knell J, et al. Long-term outcomes of severe surgical necrotizing enterocolitis. J Pediatr Surg. 2020;55(5):848–851. doi:10.1016/j.jpedsurg.2020.01.019
14. Kliegman RM, St Geme JW III, Blum NJ, Tasker RC, Wilson KM, Schuh AM, Mack CL, eds. Nelson Textbook of Pediatrics. 22nd ed. Elsevier; 2025.
15. Kenner C, Altimier LB, Boykova MV, eds. Comprehensive Neonatal Nursing Care. 7th ed. Springer Publishing Company; 2026.
16. Fisher JG, Jones BA, Gutierrez IM, et al. Mortality associated with laparotomy-confirmed neonatal spontaneous intestinal perforation: a prospective 5-year multicenter analysis. J Pediatr Surg. 2014;49(8):1215–1219. doi:10.1016/j.jpedsurg.2013.11.051
17. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990;336(8730):1519–1523. doi:10.1016/0140-6736(90)93304-8
18. Quigley M, Embleton ND, Meader N, McGuire W. Donor human milk for preventing necrotising enterocolitis in very preterm or very low-birthweight infants. Cochrane Database Syst Rev. 2024;9:CD002971. doi:10.1002/14651858.CD002971.pub6
19. Gregory KE, DeForge CE, Natale KM, Phillips M, Van Marter LJ. Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation. Adv Neonatal Care. 2011;11(3):155–164. doi:10.1097/ANC.0b013e31821baaf4
20. Yee WH, Soraisham AS, Shah VS, et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics. 2012;129(2):e298–e304. doi:10.1542/peds.2011-2022
21. Gordon PV. Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr Res. 2009;65(2):138–144. doi:10.1203/PDR.0b013e31818c7920
22. Blakely ML, Tyson JE, Lally KP, et al. Initial laparotomy versus peritoneal drainage in extremely low birthweight infants with surgical necrotizing enterocolitis or isolated intestinal perforation: a multicenter randomized clinical trial. Ann Surg. 2021;274(4):e370–e380. doi:10.1097/SLA.0000000000005099
23. Touloukian RJ, Smith GJ. Normal intestinal length in preterm infants. J Pediatr Surg. 1983;18(6):720–723. doi:10.1016/s0022-3468(83)80011-6
24. Squires RH, Duggan C, Teitelbaum DH, et al. Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr. 2012;161(4):723–728.e2. doi:10.1016/j.jpeds.2012.03.062
25. Morgan J, Bombell S, McGuire W. Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2013;(3):CD000504. doi:10.1002/14651858.CD000504.pub4
26. Randell RL, Balevic SJ, Greenberg RG, et al. Metronidazole exposure–response and safety in infants. Antimicrob Agents Chemother. 2025;69(11):e00377-25. doi:10.1128/aac.00377-25
27. Poindexter B; Committee on Fetus and Newborn. Use of probiotics in preterm infants. Pediatrics. 2021;147(6):e2021051485. doi:10.1542/peds.2021-051485
28. US Food and Drug Administration. Warning regarding use of probiotics in preterm infants (Dear Health Care Provider letter). September 29, 2023. https://www.fda.gov/media/172606/download
29. Oddie SJ, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev. 2021;8(8):CD001241. doi:10.1002/14651858.CD001241.pub8
30. Gharpure V. Neonatal necrotizing enterocolitis. J Neonatal Surg. 2012;1(2):34. PMID: 26023393
31. NHS England. Necrotising enterocolitis clinical and radiological diagnosis. NHS Data Model and Dictionary (archived release, July 2026). Accessed October 7, 2026. https://archive.datadictionary.nhs.uk/DD%20Release%20July%202026/attributes/necrotising_enterocolitis_clinical_and_radiological_diagnosis.html
32. Wexler HA. The persistent loop sign in neonatal necrotizing enterocolitis: a new indication for surgical intervention? Radiology. 1978;126(1):201–204. doi:10.1148/126.1.201
33. Leonard T Jr, Johnson JF, Pettett PG. Critical evaluation of the persistent loop sign in necrotizing enterocolitis. Radiology. 1982;142(2):385–386. doi:10.1148/radiology.142.2.7054826
34. Australasian Neonatal Medicines Formulary. Gentamicin, version 4.0. April 24, 2024. https://www.seslhd.health.nsw.gov.au/sites/default/files/groups/Royal_Hospital_for_Women/Neonatal/Neomed/Gentamicin_ANMFv4.0_20240424.pdf